Inkorporationsmessungen bei Angehorigen Von radioiodtherapiepatienten nach Therapie benigner Erkrankungen der Schilddruse

Translated title of the contribution: Measurement of incorporation in family members of patients with benign thyroid diseases after radioiodine therapy

M. Laßmann*, H. Hänscheid, L. F. Schelper, C. Körber, C. Reiners

*Corresponding author for this work
16 Citations (Scopus)

Abstract

Aim: Patients exhale I-131 after radioiodine therapy. In this study we quantify the amount of radioactivity and resulting thyroid doses found in people living in close contact to patients treated with I-131 after their release from a therapy ward. Methods: For 31 relatives of 25 patients treated with I-131 the incorporation was monitored using the thyroid probe of a whole body counter. These values are used for a determination of thyroid doses. Results: 11 of the 31 monitored persons had a thyroid activity of less than the minimal detectable activity of 13 Bq. The mean value of the remaining 20 people was 104 Bq in the thyroid resulting in a mean thyroid dose of 0.2 mSv (Maximum: 2 mSv). Conclusion: The intake of I-131 for persons in close contact to patients after dismissal from a therapy ward is low. In no case an effective dose exceeding 1 mSv was observed.

Translated title of the contributionMeasurement of incorporation in family members of patients with benign thyroid diseases after radioiodine therapy
Original languageGerman
JournalNuklearMedizin
Volume37
Issue number3
Pages (from-to)120-123
Number of pages4
ISSN0029-5566
DOIs
Publication statusPublished - 05.1998

Fingerprint

Dive into the research topics of 'Measurement of incorporation in family members of patients with benign thyroid diseases after radioiodine therapy'. Together they form a unique fingerprint.

Cite this